These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18376098)

  • 21. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation.
    Stefano JL; Abbasi S; Pearlman SA; Spear ML; Esterly KL; Bhutani VK
    Am Rev Respir Dis; 1991 Feb; 143(2):236-9. PubMed ID: 1990934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Advances in the Treatment of Preterm Newborn Infants with Patent Ductus Arteriosus.
    Sallmon H; Koehne P; Hansmann G
    Clin Perinatol; 2016 Mar; 43(1):113-29. PubMed ID: 26876125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patent ductus arteriosus in the neonate.
    Gersony WM
    Pediatr Clin North Am; 1986 Jun; 33(3):545-60. PubMed ID: 3520463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
    Ohlsson A; Walia R; Shah SS
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic management of patent ductus arteriosus.
    Bhatt V; Nahata MC
    Clin Pharm; 1989 Jan; 8(1):17-33. PubMed ID: 2643499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To Feed or Not to Feed: A Critical Overview of Enteral Feeding Management and Gastrointestinal Complications in Preterm Neonates with a Patent Ductus Arteriosus.
    Martini S; Aceti A; Galletti S; Beghetti I; Faldella G; Corvaglia L
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31892190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic strategy of patent ductus arteriosus in extremely preterm infants.
    Su BH; Lin HY; Chiu HY; Tsai ML; Chen YT; Lu IC
    Pediatr Neonatol; 2020 Apr; 61(2):133-141. PubMed ID: 31740267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of indomethacin on closure of ductus arteriosus in very-low-birthweight neonates.
    Godambe S; Newby B; Shah V; Shah PS
    Acta Paediatr; 2006 Nov; 95(11):1389-93. PubMed ID: 17062465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patent ductus arteriosus in premature infants: a review of current management.
    Neal WA; Mullett MD
    Pediatr Cardiol; 1982; 3(1):59-63. PubMed ID: 7155941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes.
    Laughon M; Bose C; Clark R
    J Perinatol; 2007 Mar; 27(3):164-70. PubMed ID: 17251985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Problem of patent ductus arteriosus in premature infants.
    Heymann MA; Hoffman JI
    Paediatrician; 1978; 7(1-3):3-17. PubMed ID: 724268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term variability of heart rate increases with successful closure of patent ductus arteriosus in preterm infants.
    Prietsch V; Maier R; Schmitz L; Obladen M
    Biol Neonate; 1992; 61(3):142-9. PubMed ID: 1610941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal-pro-brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.
    Nuntnarumit P; Chongkongkiat P; Khositseth A
    Acta Paediatr; 2011 Sep; 100(9):1217-21. PubMed ID: 21457304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of patent ductus arteriosus in preterm infants--where do we stand?
    Mitra S; Rønnestad A; Holmstrøm H
    Congenit Heart Dis; 2013; 8(6):500-12. PubMed ID: 24127861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.